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OBJECTIVES We sought to determine if the occurrence of postoperative atrial fibrillation (AF) affects early
or late mortality following coronary artery bypass surgery (CABG).
BACKGROUND Atrial fibrillation is the most common arrhythmia seen following CABG.
METHODS The Texas Heart Institute Cardiovascular Research Database was used to identify all patients
that developed AF after isolated initial CABG from January 1993 to December 1999
(n  994). This population was compared with patients who underwent CABG during the
same period but did not develop AF (n  5,481). In-hospital end points were adjusted using
logistic regression models to account for baseline differences. Long-term survival was
evaluated using a retrospective cohort design, where Cox proportional hazards methods were
used to adjust for baseline differences, and with case-matched populations (n  390, 195 per
arm).
RESULTS Atrial fibrillation was diagnosed in 16% of the population. Postoperative AF was associated
with greater in-hospital mortality (odds ratio [OR] 1.7, p 0.0001), more strokes (OR 2.02,
p  0.001), prolonged hospital stays (14 vs. 10 days, p  0.0001), and a reduced incidence
of myocardial infarction (OR 0.62, p  0.01). At four to five years, survival was worse in
patients who developed postoperative AF (74% vs. 87%, p  0.0001 in the retrospective
cohort; 80% vs. 93%, p  0.003 in the case-matched population). On multivariate analysis,
postoperative AF was an independent predictor of long-term mortality (adjusted OR 1.5,
p  0.001 in the retrospective cohort; OR 3.4, p  0.0018 in the case-matched population).
CONCLUSIONS The occurrence of AF following CABG identifies a subset of patients who have a reduced
survival probability following CABG. The impact of various strategies, such as antiarrhyth-
mics and warfarin, aimed at reducing AF and its complications deserves further
study. (J Am Coll Cardiol 2004;43:742–8) © 2004 by the American College of Cardiology
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ptrial fibrillation (AF) is the most common rhythm distur-
ance following coronary artery bypass surgery (CABG) (1).
ith continuous electrocardiographic monitoring, reported
ostoperative AF incidences range from 25% to 40% post-
ABG and up to 62% after a combined CABG and valve
rocedure (1–3). The occurrence of postoperative AF has
See page 749
een associated with prolonged length of stay (LOS),
ntensive care unit readmission, a greater need for reintu-
ation, persistent congestive heart failure (CHF), stroke,
nd increased overall costs (4–8). Although studies abound
xamining the predictors of AF, cost impact, LOS, and the
ffects of various prophylactic interventions aimed at reduc-
ng the incidence of AF and LOS, none have systematically
eviewed the impact of postoperative AF upon prognosis for
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Manuscript received June 25, 2002; revised manuscript received October 25, 2002,
accepted November 13, 2003.urvival. This study was undertaken to determine the impact
f postoperative AF on in-hospital and late outcomes,
ddressing specifically the issue of mortality.
ETHODS
tudy population. RETROSPECTIVE COHORT. The Texas
eart Institute (THI) Cardiovascular Research database was
sed to identify all patients who developed any AF as a
ostoperative complication following their first isolated re-
ascularization procedure from January 1993 to December
999 (AF, n 994). Those who did not develop postoperative
F during the same period served as the control population
no-AF, n  5,481). Patients were excluded if they had
reexisting AF of any type, thyroid disease, or concomitant
ascular or valve surgery. The study was limited to residents of
exas.
ASE-MATCHED SUBSTUDY. The case-match study popula-
ion was derived by matching the AF and no-AF populations
erived from the retrospective cohort for as many variables as
ossible, with emphasis on matching predictors of mortality
nd postoperative complications associated with early mortal-
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March 3, 2004:742–8 Post-CABG AF and Mortalityty. This was done to reduce the impact of early mortality and
ighlight longer term differences.
tudy design and end points. The study design is depicted
n Figure 1. The two populations were compared for the
n-hospital end points of early death (30 days), myocardial
nfarction (MI), stroke, and LOS using a retrospective
ohort design. Logistic regression analysis was utilized to
tatistically adjust for differences in baseline differences and
onfounding variables. Long-term mortality was then eval-
ated simultaneously using two parallel methods: a retro-
pective cohort design, where Cox proportional hazards
ethods were used to adjust for differences in baseline
haracteristics and comorbidities, and case-matching meth-
ds. Follow-up was obtained using the THI Cardiovascular
esearch database in conjunction with the state’s vital
tatistics system.
efinitions. Postoperative AF was defined by the docu-
entation of AF of any duration at any time in the
ostoperative period on a physician assessment, on the basis
f a rhythm strip or 12-lead electrocardiogram recording.
ariables defined by patient history were hypertension, angina
Abbreviations and Acronyms
AF  atrial fibrillation
CABG  coronary artery bypass graft surgery
CAD  coronary artery disease
CHF  congestive heart failure
CI  confidence intervals
COPD  chronic obstructive pulmonary disease
CPK  creatine phosphokinase
CVD  cerebrovascular disease
IMA  internal mammary artery
LOS  length of stay
MI  myocardial infarction
OR  odds ratio
PVD  peripheral vascular disease
THI  Texas Heart Institute
TIA  transient ischemic attack
igure 1. Study design. AF  atrial fibrillation; CABG  coronary artery
ypass graft surgery; THI  Texas Heart Institute.everity, congestive heart failure (CHF), family history of
AD, previous MI, renal insufficiency, diabetes mellitus,
eripheral vascular disease (PVD), transient ischemic attack
TIA), cerebrovascular disease (CVD), abdominal aortic
neurysm, and chronic obstructive pulmonary disease
COPD). Patient history was obtained by interview at
ospital or clinic presentation and entered prospectively into
he database. Angina was defined by the Canadian Cardio-
ascular Society Classification and CHF by the New York
eart Association criteria. Postoperative MI was defined by
he elevation of creatine phosphokinase (CPK) and
PK-MB 3 the upper limits of normal, or by new Q
aves on follow-up electrocardiograms.
tatistical analysis. Baseline characteristics are presented
s mean values with standard deviation or as percentage of
otal patients with available data in each group. Pearson’s
hi-square test for discrete variables and Student t test
ontinuous variables were used for comparisons. The SAS
ax/VMS Version 6.09 (SAS Institute, North Carolina)
as used for analysis. A value of p  0.05 was considered
ignificant.
Logistic regression and Cox proportional hazard models
tilizing a forward stepwise variable selection process were
eveloped to determine which clinical and angiographic
ariables were associated with early and late mortality,
espectively. After stepwise models were developed for
redicting mortality using patient risk factors, the presence
r absence of AF (AF or no-AF, coded as 1 and 0,
espectively) was then added to the models to determine if
urvival was dependent on the presence or absence of AF
hile controlling for significant patient risk factors. The
xponential of the coefficient of this variable is the hazard
atio for AF:no-AF. This hazard (or odds) ratio is the ratio
f mortality of the AF to no-AF population at any given
oint in time, controlling for differences in patient covari-
tes or risk factors.
In comparing the long-term survival of each of the
atient subgroups, a different model was used for each group
sing Cox proportional hazards models that retain only the
ignificant predictors of survival. The 95% confidence in-
ervals (CIs) for the hazard ratios were calculated to test for
ignificant differences in survival between AF and no-AF.
ogarithms of the ratios and their CIs were then computed
o that intervals on either side of 1 would have values that
ere comparable.
To measure survival differences in percentages rather than
n relative terms for each patient subgroup, a Cox propor-
ional hazards model for the subgroup was used to construct
djusted Kaplan-Meier survival curves for the AF and the
o-AF patients. The adjusted survivals were calculated from
he Cox models fixing the coefficients for the other covari-
tes at their means and varying the coefficient for the
rocedure. The resulting two curves were plotted for each
ubgroup for comparison.
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etrospective cohort study. Between January 1, 1993, and
ecember 31, 1999, a total of 6,477 patients who were
exas residents underwent their isolated first CABG at the
HI. Of these, 994 patients (16%) developed AF during
able 1. Retrospective Cohort: Clinical Characteristics
AF (%)
n  994
No-AF (%)
n  5,481 p Value
ean age (yrs) 67.9  9.6 62.2  10.7  0.0001
emale 26.7 26.1 0.7
ypertension 71.4 67.7 0.02
moker 55.2 53.9 0.44
ypercholesterolemia 46.8 50.4 0.04
nstable angina 62.6 62.5 0.96
YHA functional class
3 to 4
85.4 86.6 0.33
ongestive heart failure 15.6 12.3 0.005
ean EF (%) 48.9  14 49.4  13 0.36
rior myocardial
infarction
17.4 15.4 0.12
erebrovascular disease 7.8 5.6 0.006
rior TIA 4.98 3.02 0.0016
eripheral vascular disease 27.9 17.5  0.0001
OPD 28.2 22.2  0.0001
iabetes 10.8 11 0.84
enal insufficiency 10.5 9.6 0.38
umber of vessels 0.013
1-vessel 9 12
2-vessel 28 28
3-vessel 60 56
besity 15.9 19.9 0.004
se of IABP 5.8 3.7 0.0018
F  atrial fibrillation; COPD  chronic obstructive pulmonary disease; EF 
jection fraction; IABP  intraaortic balloon pump; NYHA  New York Heart
ssociation; TIA  transient ischemic attack.Figure 2. Actuarial and risk-adjusted in-hospital outcomes.heir postoperative course. The mean follow-up was 4  2
ears. Follow-up was 100%.
Baseline patient characteristics are presented in Table 1.
atients who developed AF were older, more often hyperten-
ive, had COPD, non-coronary vascular disease, CHF, and
ore severe underlying CAD. They were also more likely to
ave had an IABP placed and longer cardiopulmonary bypass
imes. Conversely, they were less likely to be obese or hyper-
holesterolemic. There was no difference in the prevalence of
iabetes mellitus or prior MI. Multivariate predictors for the
ccurrence of postoperative AF were age65 years (odds ratio
OR] 2.4, 95% CI 2.06 to 2.74, p  0.0001), COPD (OR
.26, 95% CI 1.08 to 1.47, p  0.004), PVD (OR 1.54, 95%
I 1.31 to 1.81, p  0.0001), and preprocedure use of an
ABP (OR 1.71, 95% CI 1.26 to 2.32, p  0.0005).
In-hospital outcomes are presented in Figure 2. Patients
ith postoperative AF had significantly greater incidences
f stroke and early death. The LOS was longer for patients
ith AF, but the MI rate was less. While in hospital,
atients who developed AF were more likely to have an
nfection, CHF, respiratory failure, renal failure, shock,
ultiorgan system failure, or a cardiac arrest. At discharge,
hey were more likely to be sent home on anticoagulants
nd/or antiarrhythmic therapy (Table 2).
Long-term mortality was significantly poorer for patients
ho developed postoperative AF. Actuarial (observed) sur-
ival at one and four years were 87% versus 94% and 74%
ersus 87% (adjusted OR 1.5 over the time period, 95% CI
.26 to 1.77, p  0.0001), for the AF and no-AF popula-
ions, respectively. These differences persisted after exclud-
ng early mortality (adjusted OR 1.4 over the time period,
5% CI 1.12 to 1.68, p  0.002). Multivariate predictors ofAF  atrial fibrillation; MI  myocardial infarction.
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March 3, 2004:742–8 Post-CABG AF and Mortalityong-term mortality are presented in Table 3. Figures 3A
nd 3B show the adjusted survival curves for the retrospec-
ive cohort, with and without the influence of early mortal-
ty. Both curves demonstrate a continual divergence.
ortality in the case-matched population. A total of 390
atients (195 per arm) were identified. Clinical characteris-
ics of patients selected for the case-matched study are
epicted in Table 4. To reduce the impact of early mortality
nd the possibility that postoperative AF was a marker of a
able 2. Retrospective Cohort: In-Hospital Outcomes/Variables
AF (%)
n  994
No-AF (%)
n  5,481
p
Value
omplications
Myocardial infarction 4.4 7.4  0.0001
Stroke 5.2 1.7  0.0001
Any infection 17.2 5.9  0.0001
Respiratory failure 28.5 12.5  0.0001
CHF 2.4 1.1 0.0016
Hypotension requiring
pressors
17.2 6.1  0.0001
Renal failure 12.1 4.7  0.0001
Shock 2.5 1.02 0.0001
Multisystem failure 0.79 0.33 0.03
CP arrest 2.4 0.8  0.0001
ischarge on anticoagulants 14 6.25  0.0001
ischarge on any
antiarrhythmics
31.4 7.3  0.0001
F  atrial fibrillation; CP  cardiopulmonary; CHF  congestive heart failure.
able 3. Retrospective Cohort: Multivariate Predictors of Long-
erm Mortality
Adjusted
OR 95% CI
p
Value
ostoperative AF 1.5 1.26–1.77  0.0001
se of IMA 0.76 0.64–0.89 0.0008
HF 1.71 1.46–2.01  0.0001
YHA functional class
3 to 4
1.56 1.21–2.03 0.0007
VD 1.33 1.14–1.55 0.0003
umber of vessels diseased 1.13 1.03–1.24 0.0079
rgent procedure 1.38 1.16–1.64 0.0002
re-IABP 1.42 1.11–1.83 0.0059
iabetes 1.37 1.15–1.64 0.0038
ge 65 yrs 2.04 1.76–2.37  0.0001
enal insufficiency 1.67 1.39–1.99  0.0001
rior TIA 1.55 1.19–2.03 0.0013
VD 1.43 1.15–1.78 0.0014
ostoperative
Stroke 1.62 1.24–2.12 0.0005
MI 1.34 1.06–1.69 0.0125
Hypotension requiring
pressors
2.77 2.03–3.79  0.0001
Renal failure 1.78 1.48–2.14  0.0001
ischarge medications
Beta-blocker 0.63 0.54–0.72  0.0001
ASA 0.53 0.47–0.61  0.0001
Hypolipidemic 0.74 0.59–0.91 0.0055
F  atrial fibrillation; ASA  aspirin; CHF  congestive heart failure;
I confidence interval; CVD cerebrovascular disease; IMA internal mammary
rtery; MI  myocardial infarction; NYHA  New York Heart Association;
R  odds ratio; Pre-IABP  preprocedure use of an intraaortic balloon pump;aVD  peripheral vascular disease; TIA  transient ischemic attack.erminal in-hospital illness, the matching algorithm was
esigned to match for the presence or absence of postoper-
tive complications associated with early mortality (Table
). The populations compared were reasonably well
atched. Table 5 demonstrates equivalent in-hospital out-
omes in the case-matched population and supports the
dequacy of the matching process.
The mean follow-up was 5  2 years. Actuarial survival
t one, three, and five years were 96% versus 98%, 86% vs.
4%, and 80% vs. 93% (OR 3.4 over the time period, 95%
I 1.58 to 7.45, p  0.0018), for the AF and no-AF
opulations, respectively. Figure 4 shows the survival curves
or the case-matched population. Consistent with the find-
ngs in the retrospective cohort, these curves are diverging
nd suggestive of an ongoing risk associated with postop-
rative AF.
ubset analysis. Multivariate predictors of late mortality in
he patients who developed postoperative AF and in those
ho did not are depicted in Table 6. Use of an IMA graft
nd discharge on a beta-blocker or aspirin conferred similar
rotective effects on both populations. Discharge on any
igure 3. Risk-adjusted survival in all patients (A) including early (30
ays) mortality and (B) excluding early mortality. Note the continual
ivergence of both curves. AF  atrial fibrillation; OR  odds ratio.ntiarrhythmic agent was associated with a 32% reduction in
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Post-CABG AF and Mortality March 3, 2004:742–8ll-cause mortality (OR 0.68, p  0.0106) only in patients
ith postoperative AF, whereas discharge on warfarin
xerted a neutral effect in both populations. Hypolipidemic
herapy improved whereas diabetes negatively affected the
urvival of the no-AF patients, but did not appear to
nfluence outcomes in patients with postoperative AF.
ariables of CHF, poor functional class, and severity of
oronary and noncoronary vascular disease were associated
ith increased mortality in both populations.
ISCUSSION
lthough the morbidity of postoperative AF is well docu-
ented, it has not been clearly established whether postop-
rative AF is associated with excess mortality. In earlier
tudies, the occurrence of postoperative AF did not appear
able 4. Case-Matched: Clinical Characteristics and In-
ospital Outcomes/Variables
Variable
AF (%)
n  195
No-AF (%)
n  195
ean age (yrs) 66  8 65  9
emale 17.7 17.7
ypertension 67.6 68.7
moker 54.7 55.1
ypercholesterolemia 50.6 50.6
nstable angina 64.5 65.3
YHA functional class 3 to 4 91.3 91.3
ean EF (%) 51  12 50  12
rior myocardial infarction 9.4 9.4
erebrovascular disease 1.1 1.1
rior TIA 0 0
eripheral vascular disease 12.4 12.4
OPD 22.6 16.6
iabetes 3.4 3.4
enal insufficiency 7.2 6.4
umber of vessels
1-vessel 9.1 9.1
2-vessel 31.3 31.3
3-vessel 59.6 59.6
se of an IMA graft 90.6 90.2
ostoperative complications
Myocardial infarction 1.5 1.5
Stroke 0 0
Any infection 1.9 1.9
Respiratory failure 5.7 5.7
CHF 0 0
Hypotension requiring pressors 0 0
Renal failure 0 0
Multisystem failure 0 0
ll p values 0.05.
EF  ejection fraction; other abbreviations as in Tables 2 and 3.
able 5. Case-Matched: In-Hospital Outcomes
Outcome
AF No-AF p
Value(n  195) (n  195)
eath 1.0 0 0.16
I 1.5 2.1 0.7
troke 0 0 1.0
ospital stay 9.98 9.13 0.24sbbreviations as in Table 3.o impact upon short and long-term outcomes (9–11). The
achyarrhythmia itself was short-lived with more than 90%
f patients reverting to sinus rhythm at six to eight weeks
ollowing surgery (11). In a study of 123 patients with
ostoperative AF identified by continuous electrocardio-
raphic monitoring, Rubin et al. found no difference in the
utcomes of angina, stroke, death, or MI while in hospital
nd at an average of 26 weeks of follow-up (10).
In more recent studies, postoperative AF has been asso-
iated with a two- to fourfold increased risk of stroke at 30
ays, a 4- to 5-day increase in hospital LOS, and an increase
n the cost of care on the order of approximately $10,000 per
atient (5,6,8,12–17). To our knowledge, only four studies
ave described an association between postoperative AF and
ortality, two of which were in non-CABG populations
4,18–20). Krowka et al. (18) and von Knorring et al. (19)
eported early mortality rates of 22% and 17%, respectively,
n patients who developed postoperative tachyarrhythmias
fter undergoing pneumonectomy for a primary pulmonary
athology. Stamou et al. (20) described significantly greater
n-hospital mortality (3% vs. 1%) in a population of 206
atients who developed AF following minimally invasive
ABG. In the only study that has looked beyond early
utcomes, Almassi et al. (4) described both an increase in
arly (5.95% vs. 2.95%) and late mortality (9.4% vs. 4.2%).
ollow-up, however, was only for six months.
Our study is consistent with the literature in that we report
imilar predictors for the development of AF, an increased
ncidence of stroke, and a prolongation of hospital stay. But
ore importantly, our study provides strong evidence that
ostoperative AF is associated with an increased early and late
ortality risk. This association persists after adjustment for
nown confounding variables such as MI, CHF, prior stroke,
IA, CVD, PVD, COPD, diabetes, and advanced age.
lthough most of the death associated with AF occurred early
n the postoperative period, the association with late mortality
emained statistically significant after exclusion of early mor-
ality and was further strengthened by consistent findings in a
igure 4. Survival in the case-matched population. Abbreviations as in
igure 3.imultaneous case-matched population. Furthermore, Kaplan-
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March 3, 2004:742–8 Post-CABG AF and Mortalityeier survival curves in both study populations with a mean of
our and up to six years of follow-up were diverging, suggesting
hat clinical recognition of this once thought temporary or
solated event identifies an ongoing or persistent effect.
The mechanisms by which postoperative AF is associated
ith mortality are speculative. In the short term, hemody-
amic compromise and CHF directly as a result of the loss
f atrial transport function may certainly contribute. In the
ong term, mechanistic and causal links are more difficult to
stablish. Possibilities include the development of CHF
ith its attendant mortality risk, the occurrence of disabling
troke or other embolic catastrophes, and adverse drug
ffects, such as proarrhythmia with antiarrhythmic drugs or
emorrhage with anticoagulants. Unfortunately, it is cur-
ently unknown whether patients who have postoperative
F also tend to develop left ventricular dysfunction, chronic
r persistent AF, an increased long-term stroke risk, or even
equire additional pharmacotherapeutics. Although Loubani
t al. (21) reported a 50% persistence of AF at discharge and
able 6. Multivariate Predictors of Mortality for AF and No
F Populations
Variable Adjusted OR 95% CI p Value
F population
Use of IMA 0.691 0.52–0.92 0.0117
CHF 1.48 1.12–2.97 0.0067
NYHA class 3 to 4 1.73 1.08–2.8 0.024
PVD 1.48 1.14–1.93 0.003
No. of vessels diseased 1.14 1.04–1.24 0.0044
Postoperative
Respiratory failure 1.47 1.09–1.99 0.0123
Hypotension 1.59 1.18–2.14 0.0026
CP arrest 1.89 1.11–3.21 0.019
Renal failure 1.96 1.4–2.7  0.0001
Discharge medications
Beta-blocker 0.6 0.445–0.81 0.0008
ASA 0.56 0.43–0.74  0.0001
Antiarrhythmic 0.68 0.513–0.916 0.0106
o-AF population
Use of IMA 0.722 0.61–0.85 0.0002
CHF 1.79 1.52–2.12  0.0001
NYHA class 3 to 4 1.31 1.02–1.69 0.0381
PVD 1.36 1.16–1.59 0.0002
No. of vessels diseased 1.13 1.04–1.24 0.006
Diabetes 1.4 1.17–2.02 0.0002
Renal insufficiency 1.61 1.34–1.94  0.0001
Prior TIA 1.5 1.123–2.01 0.0061
CVD 1.58 1.26–1.98  0.0001
Postoperative
MI 1.54 1.17–2.02 0.0019
Stroke 1.98 1.42–2.76  0.0001
Hypotension 1.48 1.18–1.85 0.0007
CP arrest 1.7 1.03–2.83 0.0395
Renal failure 1.98 1.6–2.45  0.0001
Shock 3.58 2.43–5.29  0.0001
Discharge medications
Beta-blocker 0.62 0.53–0.73  0.0001
ASA 0.53 0.46–0.62  0.0001
Hypolipidemic 0.7 0.55–0.88 0.0025
bbreviations as in Tables 2 and 3.9% at six months, these data were obtained from a small wumber of patients (83 patients with postoperative AF). This
earth of knowledge is confounded by the fact that the mode
nd immediate cause of death in this particular population is
lso unknown.
An important paradigm that must be considered is that it
s not postoperative AF per se that causes an increased
ortality, but rather postoperative AF is a marker for other
onditions with a propensity for mortality, such as CHF,
eft ventricular dysfunction, advanced age, and other comor-
idities. Stated differently, patients with AF are just sicker.
atients who developed AF were older and with more
omorbidities. Although this statement is appealing, our
tudy shows that the converse is true. Using statistical
ethods identical to those used in the Framingham study
nd other large population-based studies that have delin-
ated risk factors for disease processes, we have shown that
ostoperative AF is independently associated with a reduced
urvival. This predictive power of AF persists even after
tatistical adjustment for confounding variables and comor-
id conditions. In order to exclude the possibility that
ostoperative AF may occur in association with preterminal
vents and is thus not causally related, comparisons were
erformed censoring in-hospital mortality. The association
etween postoperative AF and reduced survival remained
nd the ongoing effect was highlighted by continual diver-
ence of survival curves. Furthermore, the case-control
omparison that reduces the effect of comorbidities upon
ubsequent differences in survival produced consistent re-
ults.
Our data also show a reduction in the incidence of postop-
rative MI and suggest improved survival in patients dis-
harged on antiarrhythmic therapy. The possible reasons for a
educed incidence of postoperative MI, which differs from that
eported in the literature, include an increased likelihood of
eceiving beta-blockade and anticoagulation and antiplatelet
herapy, as well as the possibility of random error. On subset
nalysis, the findings of improved survival with use of an IMA,
spirin, or beta-blockers, and reduced survival with CHF, poor
unctional class, and more severe vascular disease are consistent
ith the literature. However, the most intriguing finding on
ubset analysis is the survival benefit in patients discharged on
ny antiarrhythmic therapy. In the THI cardiovascular re-
earch database, antiarrhythmic therapy is coded if patients are
ischarged on any of the class I or III agents by the Vaughan-
illiams classification. Although a 32% relative risk reduction
n mortality is noteworthy and suggests benefit with these
gents, this finding must be viewed with caution. This was
btained in a retrospective nonrandomized population. The
xact identity of the antiarrhythmic agent used is unknown,
or can it be ascertained whether the antiarrhythmic was
rescribed for the postoperative AF. Nonetheless, this exciting
bservation suggests that perhaps some therapy is available that
ay improve outcomes in postoperative AF patients.
This study is limited by its retrospective nature and the
act that it comes from a single center. Although our query
as designed to include all cases of postoperative AF, the
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Post-CABG AF and Mortality March 3, 2004:742–8revalence of postoperative AF was 16%, which is signifi-
antly lower than other reports. This low prevalence may be
ttributed to, at least in part, the exclusion of patients with
alvular disease and those with prior AF. However, we must
cknowledge the possibility that AF may have been under-
eported and only severe, persistent cases of postoperative
F were included, thereby biasing the data to exaggerate the
ortality difference. Our data do not permit us differentiate
etween early- or late-occurring AF or ascertain the dura-
ion of AF, factors likely to have prognostic significance.
oreover, we have insufficient data to make meaningful
onclusions on the impact of antiarrhythmics or anticoagu-
ants on mortality. The effects of treatment on outcomes are
ifficult to delineate in a longitudinal observational study
ecause sicker patients are more likely to be treated. Fur-
hermore, we do not have data on the immediate cause of
eath. Because of limited resources, we were only able to
rack deaths in Texas residents. Autopsy data were not
vailable and the cause of death listed in the field was not
elieved to be sufficiently accurate to identify cardiac death.
hus, all-cause mortality was used. As such, the mecha-
isms of postoperative AF-associated mortality remain at
est speculative. Finally, the limitations of the methodology
ust also be acknowledged. Although we have attempted to
djust for a plethora of variables, we acknowledge that
nmeasured factors can influence outcomes. In defense of
he method, studies that have utilized large observational
atabases have yielded information that were consistent
ith, and at times predicted, the results of randomized
rials. Although our data did not permit us to address the
uestions of post-discharge management, long-term or
ecurrent stroke, AF, rehospitalization, freedom from symp-
oms or repeat revascularization, the follow-up data for our
ole end point, death, is irrefutable. In spite of these
imitations, our investigation supports the contention that
ostoperative AF is associated with excess mortality, which
ersists after adjustment for coexisting comorbid conditions.
ONCLUSIONS
ostoperative AF is associated with an increased hospital
tay, an increased early stroke risk, and reduced in-hospital
nd long-term survival. This association is independent of
oexisting cardiovascular disease and comorbidities. The
echanisms underlying this excess mortality are unknown.
he impact of various therapies aimed at reducing postop-
rative AF and its complications needs further investigation.
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